Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Wntrix Inc
Profile last edited on: 6/13/21      CAGE: 7BQ98      UEI: HE6LHLBVCLY5

Business Identifier: Antibody drugs having cancer killing capability
Year Founded
2014
First Award
2017
Latest Award
2017
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

26 Glowing Star Place
The Woodlands, TX 77382
   (917) 459-3240
   N/A
   www.wntrix.com
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

Wntrix Inc is a developer of antibody drugs targeted for cancer treatment. Wntrix Inc are residents in the Johnson and Johnson Innovation Center, where the company essentially focuses on oncology.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$225,000
Phase II Dollars
$0
Total Awarded
$225,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2017 1 NIH $225,000
Project Title: Investigation of Antibody-Drug Conjugates of a Novel Target
0 1 NIH $400,000
Project Title: Development of drug conjugates of R-spondin peptibodies for the treatment of colorectal cancer

Key People / Management

  Jie Cui -- President

  Qingyun Liu

Company News

There are no news available.